A variety of signaling pathways including TNF-α, KRAS, IL-6/JAK/STAT3, IL-2/STAT5, epithelial-mesenchymal transition, oxidative phosphorylation, and mTOR were found to be significantly associated with TRPs in pan-cancer. This evidence concerns the gene IL2 and cancer.